These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 19623543

  • 1. Epigenetic regulation of Myc on retinoic acid receptor beta and PDLIM4 in RWPE1 cells.
    He M, Vanaja DK, Karnes RJ, Young CY.
    Prostate; 2009 Nov 01; 69(15):1643-50. PubMed ID: 19623543
    [Abstract] [Full Text] [Related]

  • 2. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W.
    Cancer; 2005 Oct 15; 104(8):1609-19. PubMed ID: 16134180
    [Abstract] [Full Text] [Related]

  • 3. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG.
    Cancer Res; 2001 Dec 15; 61(24):8611-6. PubMed ID: 11751372
    [Abstract] [Full Text] [Related]

  • 4. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, Yoo HS, Choi JY, Bae YS, Yeom YI.
    Gastroenterology; 2010 May 15; 138(5):1898-908. PubMed ID: 20038433
    [Abstract] [Full Text] [Related]

  • 5. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
    Prostaglandins Other Lipid Mediat; 2007 Jan 15; 82(1-4):185-97. PubMed ID: 17164146
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.
    Lodygin D, Diebold J, Hermeking H.
    Oncogene; 2004 Dec 02; 23(56):9034-41. PubMed ID: 15489902
    [Abstract] [Full Text] [Related]

  • 8. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR, Roberts JL, Fu VX, Jarrard DF.
    J Urol; 2007 Mar 02; 177(3):822-31. PubMed ID: 17296351
    [Abstract] [Full Text] [Related]

  • 9. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma.
    Wang Y, Fang MZ, Liao J, Yang GY, Nie Y, Song Y, So C, Xu X, Wang LD, Yang CS.
    Clin Cancer Res; 2003 Nov 01; 9(14):5257-63. PubMed ID: 14614007
    [Abstract] [Full Text] [Related]

  • 10. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
    Shiina H, Breault JE, Basset WW, Enokida H, Urakami S, Li LC, Okino ST, Deguchi M, Kaneuchi M, Terashima M, Yoneda T, Shigeno K, Carroll PR, Igawa M, Dahiya R.
    Cancer Res; 2005 Mar 15; 65(6):2130-8. PubMed ID: 15781623
    [Abstract] [Full Text] [Related]

  • 11. Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene.
    Zhang J, Liu L, Pfeifer GP.
    Oncogene; 2004 Mar 18; 23(12):2241-9. PubMed ID: 14691453
    [Abstract] [Full Text] [Related]

  • 12. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR.
    Nat Genet; 2003 Jan 18; 33(1):61-5. PubMed ID: 12496760
    [Abstract] [Full Text] [Related]

  • 13. PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer.
    Vanaja DK, Ballman KV, Morlan BW, Cheville JC, Neumann RM, Lieber MM, Tindall DJ, Young CY.
    Clin Cancer Res; 2006 Feb 15; 12(4):1128-36. PubMed ID: 16489065
    [Abstract] [Full Text] [Related]

  • 14. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
    Zhuang Y, Faria TN, Chambon P, Gudas LJ.
    Mol Cancer Res; 2003 Jun 15; 1(8):619-30. PubMed ID: 12805409
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T.
    Cancer Res; 2008 Jun 01; 68(11):4123-32. PubMed ID: 18519671
    [Abstract] [Full Text] [Related]

  • 16. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
    Petty WJ, Li N, Biddle A, Bounds R, Nitkin C, Ma Y, Dragnev KH, Freemantle SJ, Dmitrovsky E.
    J Natl Cancer Inst; 2005 Nov 16; 97(22):1645-51. PubMed ID: 16288117
    [Abstract] [Full Text] [Related]

  • 17. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.
    Mol Cancer; 2008 Nov 06; 7():83. PubMed ID: 18990230
    [Abstract] [Full Text] [Related]

  • 18. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G, Barker MA, Kaur P, Groshen S, Jones LW, Imam SA, Boyd VL.
    Anal Biochem; 2009 Sep 15; 392(2):117-25. PubMed ID: 19505431
    [Abstract] [Full Text] [Related]

  • 19. Functional epigenomics identifies genes frequently silenced in prostate cancer.
    Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H.
    Cancer Res; 2005 May 15; 65(10):4218-27. PubMed ID: 15899813
    [Abstract] [Full Text] [Related]

  • 20. Epigenetic regulation of human bone morphogenetic protein 6 gene expression in prostate cancer.
    Tamada H, Kitazawa R, Gohji K, Kitazawa S.
    J Bone Miner Res; 2001 Mar 15; 16(3):487-96. PubMed ID: 11277266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.